Status:
UNKNOWN
Small Molecule LCDM and GV Oocyte
Lead Sponsor:
Peking University People's Hospital
Conditions:
Assisted Reproduction
Eligibility:
FEMALE
Brief Summary
Immature eggs obtained during the oocyte retrieval cycle are discarded as medical waste because they cannot complete fertilization, but each egg is important for people with poor clinical outcome. In ...
Eligibility Criteria
Inclusion
- ICSI cycle with more than 2 GV oocytes
Exclusion
- The etiological diagnosis is that the man has extremely severe oligoasthenospermia and primary azoospermia. These patients can lead to low fertilization rate due to sperm, so they are excluded from the group.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05356429
Start Date
May 1 2022
End Date
December 31 2023
Last Update
May 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.